NO20091467L - Farmasoytiske formuleringer som omfatter klopidogrel - Google Patents
Farmasoytiske formuleringer som omfatter klopidogrelInfo
- Publication number
- NO20091467L NO20091467L NO20091467A NO20091467A NO20091467L NO 20091467 L NO20091467 L NO 20091467L NO 20091467 A NO20091467 A NO 20091467A NO 20091467 A NO20091467 A NO 20091467A NO 20091467 L NO20091467 L NO 20091467L
- Authority
- NO
- Norway
- Prior art keywords
- clopidogrel
- pharmaceutical formulations
- melt granulate
- pharmaceutically acceptable
- melt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Smeltegranulat i form av en fast dispersjon av medikamentet i en farmasøytisk akseptabel bærer, hvori nevnte smeltegranulat omfatter en farmasøytisk aktiv forbindelse, fortrinnsvis klopidogrel, minst ett bæremateriale, og eventuelt farmasøytisk akseptable eksipienter og fremgangsmåte til fremstilling av nevnte smeltegranulat.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06019429A EP1900358A1 (en) | 2006-09-16 | 2006-09-16 | Pharmaceutical formulations comprising clopidogrel |
PCT/EP2007/008070 WO2008031623A1 (en) | 2006-09-16 | 2007-09-17 | Pharmaceutical formulations comprising clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091467L true NO20091467L (no) | 2009-04-15 |
Family
ID=37735123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091467A NO20091467L (no) | 2006-09-16 | 2009-04-15 | Farmasoytiske formuleringer som omfatter klopidogrel |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090270448A1 (no) |
EP (3) | EP1900358A1 (no) |
AT (1) | ATE552826T1 (no) |
AU (1) | AU2007296854A1 (no) |
CA (1) | CA2663311A1 (no) |
DE (1) | DE202007019385U1 (no) |
DK (1) | DK2068838T3 (no) |
ES (1) | ES2384740T3 (no) |
IL (1) | IL197089A0 (no) |
MX (1) | MX2009002356A (no) |
NO (1) | NO20091467L (no) |
NZ (1) | NZ575153A (no) |
PL (1) | PL2068838T3 (no) |
PT (1) | PT2068838E (no) |
RU (1) | RU2009114206A (no) |
WO (1) | WO2008031623A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004106344A2 (en) | 2003-04-25 | 2004-12-09 | Cadila Healthcare Limited | Salts of clopidogrel and process for preparation |
EP1900358A1 (en) | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
CN102240269B (zh) * | 2010-05-12 | 2013-04-10 | 天津泰普药品科技发展有限公司 | 结晶型硫酸氢氯吡格雷片剂的制备方法 |
EP2585161A1 (en) * | 2010-06-23 | 2013-05-01 | Stefan Kralev | Medical device for self-administration of patients with acute coronary events |
CN107501289B (zh) * | 2017-09-07 | 2019-06-14 | 山东齐都药业有限公司 | 硫酸氢氯吡格雷有关物质d的制备方法 |
CN110339178B (zh) * | 2019-06-28 | 2021-07-02 | 广州白云山天心制药股份有限公司 | 一种硫酸氢氯吡格雷固体制剂的制备方法 |
CN115737578A (zh) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
US5308621A (en) * | 1991-02-18 | 1994-05-03 | Commonwealth Scientific And Industrial Research Organisation | Ascorbic acid composition and transdermal administration method |
JP3397385B2 (ja) * | 1993-09-20 | 2003-04-14 | 第一製薬株式会社 | 崩壊遅延防止錠剤 |
KR100768034B1 (ko) * | 1999-03-17 | 2007-10-17 | 다이이찌 세이야꾸 가부시기가이샤 | 의약 조성물 |
FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
CA2363053C (en) | 2001-11-09 | 2011-01-25 | Bernard Charles Sherman | Clopidogrel bisulfate tablet formulation |
DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
DE10341264A1 (de) * | 2003-09-04 | 2005-03-24 | Grünenthal GmbH | Schmelzformulierte, multipartikuläre orale Darreichungsform |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
-
2006
- 2006-09-16 EP EP06019429A patent/EP1900358A1/en not_active Withdrawn
-
2007
- 2007-09-17 EP EP07818184A patent/EP2068838B1/en not_active Not-in-force
- 2007-09-17 CA CA002663311A patent/CA2663311A1/en not_active Abandoned
- 2007-09-17 AT AT07818184T patent/ATE552826T1/de active
- 2007-09-17 RU RU2009114206/15A patent/RU2009114206A/ru unknown
- 2007-09-17 PL PL07818184T patent/PL2068838T3/pl unknown
- 2007-09-17 NZ NZ575153A patent/NZ575153A/en not_active IP Right Cessation
- 2007-09-17 WO PCT/EP2007/008070 patent/WO2008031623A1/en active Application Filing
- 2007-09-17 PT PT07818184T patent/PT2068838E/pt unknown
- 2007-09-17 MX MX2009002356A patent/MX2009002356A/es active IP Right Grant
- 2007-09-17 EP EP11003617A patent/EP2359810A2/en not_active Withdrawn
- 2007-09-17 AU AU2007296854A patent/AU2007296854A1/en not_active Abandoned
- 2007-09-17 US US12/441,501 patent/US20090270448A1/en not_active Abandoned
- 2007-09-17 ES ES07818184T patent/ES2384740T3/es active Active
- 2007-09-17 DE DE202007019385U patent/DE202007019385U1/de not_active Expired - Lifetime
- 2007-09-17 DK DK07818184.9T patent/DK2068838T3/da active
-
2009
- 2009-02-17 IL IL197089A patent/IL197089A0/en unknown
- 2009-04-15 NO NO20091467A patent/NO20091467L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT2068838E (pt) | 2012-06-27 |
EP2359810A2 (en) | 2011-08-24 |
AU2007296854A1 (en) | 2008-03-20 |
MX2009002356A (es) | 2009-05-15 |
ES2384740T3 (es) | 2012-07-11 |
EP2068838B1 (en) | 2012-04-11 |
EP2068838A1 (en) | 2009-06-17 |
US20090270448A1 (en) | 2009-10-29 |
PL2068838T3 (pl) | 2012-10-31 |
IL197089A0 (en) | 2009-11-18 |
NZ575153A (en) | 2011-01-28 |
ATE552826T1 (de) | 2012-04-15 |
DK2068838T3 (da) | 2012-07-09 |
EP1900358A1 (en) | 2008-03-19 |
RU2009114206A (ru) | 2010-10-27 |
CA2663311A1 (en) | 2008-03-20 |
DE202007019385U1 (de) | 2012-03-29 |
WO2008031623A1 (en) | 2008-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091467L (no) | Farmasoytiske formuleringer som omfatter klopidogrel | |
WO2008014175A3 (en) | Granular pharmaceutical compositions | |
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
WO2007081948A3 (en) | Bioadhesive drug formulations for oral transmucosal delivery | |
DK1487416T3 (da) | Lægemiddelmikropartikler | |
ZA200806138B (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
WO2006055603A3 (en) | Injectable nanoparticulate olanzapine formulations | |
HRP20050371A2 (en) | Administration form for pharmaceutically active peptides with sustained release and method for the production thereof | |
WO2009027644A3 (en) | Compositions for the treatment of neoplastic diseases | |
MY148237A (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
NO20084065L (no) | Hurtig frigivelses paracetamol tabletter | |
LTPA2019508I1 (lt) | Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui | |
NL1028193A1 (nl) | Farmaceutisch werkzame verbindingen. | |
ATE536861T1 (de) | Bioerodierbare arzneimittelabgabesysteme mit verzögerter freisetzung | |
DK1795186T3 (da) | Flupirtinomfattende lægemiddelformulering med en kontrolleret frisætning af det aktive middel | |
PL1655026T3 (pl) | Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne | |
DE602005027231D1 (de) | Cylglycerolen und therapeutischen verwendungen derselben | |
WO2008101173A3 (en) | Biodegradable compositions and materials | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
WO2007016350A3 (en) | Modified release tablet formulations with enhanced mechanical properties | |
IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
DK1750765T3 (da) | Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel | |
WO2011062936A3 (en) | Self-assembled toroidal-spiral particles and manufacture and uses thereof | |
DK1151746T3 (da) | Mikro-kapsler til vedvarende frigivelse af lægemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |